Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists
出版年份 2012 全文链接
标题
Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume 17, Issue 1, Pages 17-29
出版商
Informa Healthcare
发表日期
2012-02-16
DOI
10.1517/14728214.2012.660916
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Endocannabinoids and stress
- (2016) Caitlin J. Riebe et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data
- (2012) Paola Maccioni et al. CNS & Neurological Disorders-Drug Targets
- Animal Models of Neuropsychiatric Disorders
- (2011) A.B.P. Fernando et al. Annual Review of Clinical Psychology
- The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain
- (2011) A.M. Erdozain et al. BIOCHEMICAL PHARMACOLOGY
- Endocannabinoid tone versus constitutive activity of cannabinoid receptors
- (2011) Allyn C. Howlett et al. BRITISH JOURNAL OF PHARMACOLOGY
- The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
- (2011) George Kunos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
- (2011) S. Singh et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier
- (2011) Yen-Ku Wu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk
- (2011) David R Janero et al. Expert Opinion on Drug Discovery
- An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
- (2011) Rebecca D. Crean et al. Journal of Addiction Medicine
- Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
- (2011) Zheng-Xiong Xi et al. NATURE NEUROSCIENCE
- Common cellular and molecular mechanisms in obesity and drug addiction
- (2011) Paul J. Kenny NATURE REVIEWS NEUROSCIENCE
- Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies
- (2011) Sara Jane Ward et al. Obesity
- Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
- (2011) Louis J. Aronne et al. Obesity
- Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference
- (2011) M. Daza-Losada et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Zebrafish models to study drug abuse-related phenotypes
- (2011) Adam Stewart et al. REVIEWS IN THE NEUROSCIENCES
- Ralph M. Steinman (1943-2011)
- (2011) I. Mellman et al. SCIENCE
- Energy balance regulation by endocannabinoids at central and peripheral levels
- (2011) Carmelo Quarta et al. TRENDS IN MOLECULAR MEDICINE
- SLV330, a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats
- (2010) N.M.W.J. de Bruin et al. BEHAVIOURAL BRAIN RESEARCH
- Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
- (2010) Barbara Bosier et al. BIOCHEMICAL PHARMACOLOGY
- Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif
- (2010) Laurent Hortala et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, SAR and intramolecular hydrogen bonding pattern of 1,3,5-trisubstituted 4,5-dihydropyrazoles as potent cannabinoid CB1 receptor antagonists
- (2010) Jos H.M. Lange et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
- (2010) Tricia H Smith et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal models of cannabinoid reward
- (2010) Leigh V Panlilio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a Potential Peripheral Cannabinoid-1 Receptor Inverse Agonist
- (2010) Ming-Shiu Hung et al. ChemMedChem
- Functional Interactions between Endogenous Cannabinoid and Opioid Systems: Focus on Alcohol, Genetics and Drug-Addicted Behaviors
- (2010) J. Lopez-Moreno et al. CURRENT DRUG TARGETS
- How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue
- (2010) Jesús Giraldo DRUG DISCOVERY TODAY
- Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype
- (2010) Ester Aso et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The endocannabinoid system and nondrug rewarding behaviours
- (2010) Liana Fattore et al. EXPERIMENTAL NEUROLOGY
- A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
- (2010) L J Aronne et al. INTERNATIONAL JOURNAL OF OBESITY
- A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study
- (2010) J Proietto et al. INTERNATIONAL JOURNAL OF OBESITY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity
- (2010) F. D. Christopoulou et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output
- (2010) M. N. Hill et al. JOURNAL OF NEUROSCIENCE
- Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex
- (2010) C. Q. Chiu et al. JOURNAL OF NEUROSCIENCE
- A Selective Cannabinoid-1 Receptor Antagonist, PF-95453, Reduces Body Weight and Body Fat to a Greater Extent than Pair-Fed Controls in Obese Monkeys
- (2010) J. D. Wagner et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB1 cannabinoid receptors
- (2010) Marco Bortolato et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Theme and variations on kinetics of GPCR activation/deactivation
- (2010) Jean-Pierre Vilardaga JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- When simple agonism is not enough: Emerging modalities of GPCR ligands
- (2010) Nicola J. Smith et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice
- (2010) M. A. Storr et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities
- (2010) Yinchiu Lin et al. PHARMACOLOGICAL RESEARCH
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- AM 251 differentially effects food-maintained responding depending on food palatability
- (2010) Suzanne M. Droste et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
- (2010) F.J. Bermudez-Silva et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
- (2010) Nina L. Cluny et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Randomized, controlled, double-blind trial of taranabant for smoking cessation
- (2010) Mary F. Morrison et al. PSYCHOPHARMACOLOGY
- Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
- (2009) Gunnar Thiemann et al. BEHAVIOURAL BRAIN RESEARCH
- Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
- (2009) Fabrício A. Moreira et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel thioamide derivatives as neutral CB1 receptor antagonists
- (2009) Jonas Boström et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood–brain-barrier
- (2009) Jean-Marie Receveur et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Alteration of blood-brain barrier function by methamphetamine and cocaine
- (2009) J. B. Dietrich CELL AND TISSUE RESEARCH
- Pleiotropic Effects of Rimonabant: Clinical Implications
- (2009) Jean-Pierre Despres CURRENT PHARMACEUTICAL DESIGN
- A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
- (2009) M. S. Kipnes et al. DIABETES OBESITY & METABOLISM
- Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
- (2009) David R Janero et al. EXPERT OPINION ON EMERGING DRUGS
- Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance
- (2009) David P. Finn IMMUNOBIOLOGY
- Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions
- (2009) T M Fong et al. INTERNATIONAL JOURNAL OF OBESITY
- Impairments in Endocannabinoid Signaling and Depressive Illness
- (2009) Matthew N. Hill JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presence of conspecifics and their odor-impregnated objects reverse stress-decreased neurogenesis in mouse dentate gyrus
- (2009) Chianfang G. Cherng et al. JOURNAL OF NEUROCHEMISTRY
- Central and peripheral consequences of the chronic blockade of CB1cannabinoid receptor with rimonabant or taranabant
- (2009) Elena Martín-García et al. JOURNAL OF NEUROCHEMISTRY
- CB1 Receptor-Independent Actions of SR141716 on G-Protein Signaling: Coapplication with the -Opioid Agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol Unmasks Novel, Pertussis Toxin-Insensitive Opioid Signaling in -Opioid Receptor-Chinese Hamster Ovary Cells
- (2009) R. Cinar et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
- (2009) J. A. Przybyla et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Obesity: Genes, brain, gut, and environment
- (2009) Undurti N. Das NUTRITION
- Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1
- (2009) D Proudnikov et al. PHARMACOGENOMICS JOURNAL
- The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
- (2009) Vincenzo Di Marzo PHARMACOLOGICAL RESEARCH
- New horizons for therapeutics in drug and alcohol abuse
- (2009) Bianca Jupp et al. PHARMACOLOGY & THERAPEUTICS
- The future of endocannabinoid-oriented clinical research after CB1 antagonists
- (2009) Bernard Le Foll et al. PSYCHOPHARMACOLOGY
- The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction
- (2008) José Antonio López-Moreno et al. ADDICTION BIOLOGY
- The Discovery of Taranabant, a Selective Cannabinoid‐1 Receptor Inverse Agonist for the Treatment of Obesity
- (2008) William K. Hagmann ARCHIV DER PHARMAZIE
- Cannabinoid Receptor 1 Gene Association With Nicotine Dependence
- (2008) Xiangning Chen et al. ARCHIVES OF GENERAL PSYCHIATRY
- Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats
- (2008) P AZIZI et al. BEHAVIOURAL BRAIN RESEARCH
- The endocannabinoid system in brain reward processes
- (2008) M Solinas et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake
- (2008) Carol Addy et al. Cell Metabolism
- Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence
- (2008) Michael Soyka et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant
- (2008) A. J. Scheen JOURNAL OF NEUROENDOCRINOLOGY
- End of the line for cannabinoid receptor 1 as an anti-obesity target?
- (2008) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
- (2007) J G Horswill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats
- (2007) Laura Lamota et al. NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started